|
ARGX
|
argenx SE
|
1.08%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
1.06%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
1.00%
|
US
|
NASDAQ
|
|
JAZZ
|
Jazz Pharmaceuticals plc
|
0.93%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
0.66%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.63%
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
0.61%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
0.53%
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
0.48%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.46%
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
0.41%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
0.38%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
0.37%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
0.36%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
0.34%
|
US
|
NASDAQ
|
|
CRSP
|
CRISPR Therapeutics AG
|
0.34%
|
US
|
NASDAQ
|
|
SYNH
|
Syneos Health, Inc.
|
0.33%
|
US
|
NASDAQ
|